Incidence of clinically relevant psychiatric symptoms during glioblastoma treatment: an exploratory study

por Regli, L. K. P., Huijs, S. M. H., Pasmans, R. C. O. S., Leue, C., Dijkstra, J. B., Eekers, D. B. P., Hovinga, K. E., Anten, M. H. M. E., Hoeben, A., Broen, M. P. G.
Publicado 2023

Temporal muscle thickness as an independent prognostic imaging marker in newly diagnosed glioblastoma patients: A validation study

por Broen, Martinus P G, Beckers, Rueben, Willemsen, Anna C H, Huijs, Sandra M H, Pasmans, Raphael C O S, Eekers, Daniëlle B P, Ackermans, Linda, Beckervordersandforth, Jan, van Raak, Elisabeth P M, Verduin, Maikel, Anten, Monique H M E, Hoeben, Ann, Postma, Alida A
Publicado 2022

Correlation of reduced temporal muscle thickness and systemic muscle loss in newly diagnosed glioblastoma patients

por ten Cate, Cecil, Huijs, Sandra M. H., Willemsen, Anna C. H., Pasmans, Raphael C. O. S., Eekers, Daniëlle B. P., Zegers, Catharina M. L., Ackermans, Linda, Beckervordersandforth, Jan, van Raak, Elisabeth P. M., Anten, Monique H. M. E., Hoeben, Ann, Postma, Alida A., Broen, Martinus P. G.
Publicado 2022